Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2012: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2011: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2010: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
Research Abstract |
To reveal the mechanism of the development from transient abnormal myelopoiesis (TAM) to acute megakaryoblastic leukemia (DS-AMKL) in children with Down syndrome, we analyzed these subgroups of patients (11 children with DS-AMKL, 12 children with non-DS-AMKL) by SNP array-based karyotyping and sequencing. Somatic gains were found in 7 DS-AMKL patients, while deletions were found in 8 DS-AMKL patients. Somatic gains were found in 7 non-DS-AMKL patients, while deletions were present in 5 patients. Mutational screen found GATA1mutations in 10/11 DS-AMKL, but mutations were rare in non-DS-AMKL (1/12).
|